Suppr超能文献

胸腔内注入纤溶药物治疗胸腔积脓

Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema.

作者信息

Cochran Joel B, Tecklenburg Fred W, Turner Ronald B

机构信息

Division of Pediatric Emergency/Critical Care, Medical University of South Carolina, Charleston, SC, USA.

出版信息

Pediatr Crit Care Med. 2003 Jan;4(1):39-43. doi: 10.1097/00130478-200301000-00007.

Abstract

OBJECTIVE

To describe the use of intrapleural instillation of fibrinolytic agents as adjunctive therapy for children with complicated pleural effusions and empyema.

DESIGN

Retrospective chart review.

SETTING

Tertiary care children's hospital in an academic medical center.

PATIENTS

Nineteen consecutive patients (median age, 36 months; range, 9 months to 13 yrs) with complicated pleural effusion or empyema by clinical, radiographic, and laboratory criteria who failed to have adequate drainage of the fluid collection by tube thoracostomy.

INTERVENTIONS

Patients who remained symptomatic with fever or respiratory distress and who had pleural fluid that could not be drained by tube thoracostomy were treated by intrapleural instillation of either urokinase (13 patients) or streptokinase (six patients) 8-72 hrs after chest tube insertion.

MEASUREMENTS AND MAIN RESULTS

Fibrinolytic therapy increased the volume of chest tube drainage in 15 (79%) of 19 patients. Fourteen of the 19 patients were successfully managed without referral for surgical drainage. No significant adverse events or side effects were noted.

CONCLUSION

Intrapleural instillation of fibrinolytic agents appears to be an effective and less invasive alternative to surgical drainage for children who have complicated pleural effusions or empyemas that do not drain adequately with tube thoracostomy alone.

摘要

目的

描述胸膜腔内注入纤维蛋白溶解剂作为辅助治疗儿童复杂性胸腔积液和脓胸的应用情况。

设计

回顾性病历审查。

地点

一所学术医疗中心的三级护理儿童医院。

患者

19例连续患者(中位年龄36个月;范围9个月至13岁),根据临床、影像学和实验室标准诊断为复杂性胸腔积液或脓胸,经胸腔闭式引流术未能充分排出积液。

干预措施

对胸腔闭式引流术后仍有发热或呼吸窘迫症状且胸腔积液无法通过胸腔闭式引流排出的患者,在插入胸管8 - 72小时后,胸膜腔内注入尿激酶(13例患者)或链激酶(6例患者)进行治疗。

测量指标及主要结果

19例患者中有15例(79%)纤维蛋白溶解治疗后胸腔闭式引流量增加。19例患者中有14例无需转诊至外科进行引流即成功治愈。未观察到明显不良事件或副作用。

结论

对于仅通过胸腔闭式引流术无法充分引流的儿童复杂性胸腔积液或脓胸患者,胸膜腔内注入纤维蛋白溶解剂似乎是一种有效且侵入性较小的替代手术引流的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验